Cutaneous responses to substance P and calcitonin gene-related peptide in chronic urticaria: The effect of cetirizine and dimethindene

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 54, Issue 1, 1999, Pages 46-56

  Borici Mazi, R ^a   Kouridakis, S ^a   Kontou Fili, K ^a  

^a General Military Hospital of Athens   (Greece)

Author keywords

Calcitonin gene related peptide (CGRP); Cetirizine; Chronic urticaria; Cutaneous responses; Dimethindene; H1 antagonists; Idiopathic urticaria; Pressure urticaria; Substance P.

Indexed keywords

ANTIHISTAMINIC AGENT; CALCITONIN GENE RELATED PEPTIDE RECEPTOR; CETIRIZINE; HISTAMINE; SUBSTANCE P;

ANOREXIA; ARTICLE; CHRONIC URTICARIA; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; ERYTHEMA; FATIGUE; HEADACHE; HISTAMINE BLOOD LEVEL; HUMAN; ORAL DRUG ADMINISTRATION; PALLOR; PRIORITY JOURNAL; SKIN MANIFESTATION; SOMNOLENCE; VERTIGO;

ADULT; CALCITONIN GENE-RELATED PEPTIDE; CHRONIC DISEASE; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HISTAMINE H1 ANTAGONISTS; HUMANS; HYPERSENSITIVITY, DELAYED; MALE; SKIN PHYSIOLOGY; SUBSTANCE P; URTICARIA;

EID: 0033061329     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1398-9995.1999.00726.x     Document Type: Article

References (39)

1. Foreman JC. Ncuropeptides and the pathogencsis of allergy. Allergy 1987;42:1-11.
2. Pincelli C, Fantini F, Giannetti A. Neuropeptides and skin inflammation. Dermatology 1993;187:153-158.
3. Theoharides TC. The mast cell: a neuroimmunoendocrine master player. Int J Tissue React 1996;18:1-21.
4. Gulbenkian S, Merighi A, Wharton J Varn-Dell IM, Polak JM. Ultrastructural evidence for the coexistence of calcitonin gene-related peptide and substance P in sensory vesicles of peripheral nerves in the guinea pig. J Neurocytol 1986;15:535-542.
5. Rosenfeld MG, Mermod JJ, Amara SG, et al. Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing. Nature 1983;304:129-132.
6. Foreman JC. Substance P and calcitonin gene-related peptide: effect on mast cells. Int Arch Allergy Appl Immunol 1987;82:366-371.
7. Foreman JC, Jordan CC, Oehme P, Renner H. Structure-activity relationships for some substance P-related peptides that cause wheal and flare reactions in human skin. J Physiol 1983;335:449-465.
8. Fuller RW, Conradson TB, Dixon CMS, Crossman DC, Barnes PJ. Sensory neuropeptides effects in human skin. Br J Pharmacol 1987;92:781-788.
9. Piotrowski W, Foreman JC. On the actions of substance P, somatostatin and vasoactive intestinal polypeptide on rat peritoneal mast cells and in human skin. Arch Pharmacol 1985;331:364-368.
10. Petersen LJ, Poulsen LK, Sondergaard J, Skov PS. The use of cutaneous microdialysis to measure substance P-induced histamine release in intact human skin in vivo. J Allergy Clin Immunol 1994;94:773-783.
11. Piotrowski W, Foreman JC. Some effects of calcitonin gene-related peptide in human skin and on histamine release. Br J Dermatol 1986;114:37-46.
12. Lowman MA, Benyon R, Church MK. Characterization of neuropeptide-induced histamine release from human dispersed skin mast cells. Br J Pharmacol 1988;95:122-130.
13. Borici-Mazi R, Kouridakis S, Kontou-Fili K. Cutaneous responses to VIP and SOM in healthy adults, delayed pressure and chronic idiopathic urticaria: the effect of cetirizine and dimethidene [Abstract]. J Allergy Clin Immunol 1996;97:364.
14. Juhlin L, Michaelson G. Cutaneous reactions to kallikrein, bradykinin and histamine in healthy subjects and in patients with urticaria. Acta Derm Venereol (Stockh) 1969;49:26-36.
15. Juhlin L, Rihoux JP. Effect of cetirizine on cutaneous reactions to PAF, kallikrein and serum in patients with chronic urticaria. Acta Derm Venereal (Stockh) 1990,70: 151-153.
16. Krause LB, Shuster S. Enhanced wheal and flare response to histamine in chronic idiopathic urticaria. Br J Clin Pharmacol 1985;20:486-488.
17. 4 in patients with chronic idiopathic urticaria and in normal subjects. J Allergy Clin Immunol 1990;86:759-765.
18. Juhlin L, Arendt C. Treatment of chronic urticaria with cetirizine dihydrochloride, a non-sedating antihistamine. Br J Dermatol 1987;119:67-72.
19. Kontou-Fili K, Maniatakou G, Demaka P, Gonianakis M, Paleologos G. Therapeutic effects of cetirizine in delayed pressure urticaria. I. Effects on weight tests and skin-window cytology. Ann Allergy 1990;65:517-519.
20. Kontou-Fili K, Maniatakou G, Paleologos G, Aroni K. Cetirizine inhibits delayed pressure urticaria. II. Skin biopsy findings. Ann Allergy 1990;65:520-522.
21. Neste DV, Cousseraent C, Ghys L, Rihoux JP. Agonist-antagonist interactions in the skin: comparison of effects of loratadine and cetirizine on skin vascular responses to prick tests with histamine and substance P. J Dermatol Sci 1992;4:172-179.
22. Kori-Lindner C, Beckers C, Phleps W. Dimetiden-maleate (DMM) im therapeutischen Vergleich zu antihistaminika der 2, generation. Allergo J 1997;4:204-212.
23. Phanuphak P, Schocket AL, Arroyane CM, Kohler PF. Skin histamine in chronic urticaria. J Allergy Clin Immunol 1980;65:371-375.
24. Kaplan AP, Horakova Z, Katz SI. Assessment of tissue fluid histamine levels in patients with urticaria. J Allergy Clin Immunol 1978;61:350-354.
25. Barlow RJ, Ross EL, Macdonald DM, Kobza Black A, Greaves MW. Mast cells and T-lymphocytes in chronic urticaria. Clin Exp Allergy 1995;25:317-322.
26. Delay-Goyet P, Satoh H, Lundberg JM. Relative involvement of substance P and CGRP mechanisms in antidromic vasodilatation in the rat skin. Acta Physiol Scand 1992;146:537-538.
27. 5] enkephaline. Eur J Pharmacol 1982;85:171-176.
28. Smith CH, Kepler CH, Schwanz LB, Lee TH. Mast cell number and phenotype in chronic idiopathic urticaria. J Allergy Clin Immunol 1995;96:360-364.
29. Smith CH, Barker JNWN, Morris RW, Macdonald DM, Lee TH. Neuropeptides induce rapid expression of endothelial cell adhesion molecules and elicit granulocyte infiltration in human skin. J Immunol 1993;151:3274-3282.
30. Barlow RJ, Ross EL, MacDonald D, Black AK, Greaves MW. Adhesion molecule expression and the inflammatory cell infiltrate in delayed pressure urticaria. Br J Dermatol 1994;131:341-347.
31. Haas N, Motel K, Czarnetzki BM. Comparative immunoreactivity of the cosinophil constituents MBP and ECP in different types of urticaria. Arch Dermatol Res 1995;287:180-185.
32. Brain SD, Williams TJ, Tippins JR, Morris HR, MacIntyre I. Calcitonin gene-related peptide is a potent vasodilatator. Nature 1983;313:54-56.
33. Morris HR, Panico M, Etienne T, Tippins J, Girgis SI, MacIntyre I. Isolation and characterization of human calcitonin generelated peptide. Nature 1984;308:746-748.
34. Brain SD, Williams TJ. Inflammatory oedema induced by synergism between CGRP and mediators of increased vascular permeability. Br J Pharmacol 1985;86:855-860.
35. Petersen LJ, Church MK, Skov PS. Histamine is released in the wheal but not the flare following challenge of human skin in vivo: a microdialysis study. Clin Exp Allergy 1997;27:284-295.
36. Köller M, Hilger RA, Rihoux JP, König W. Cetirizine exerts anti-inflammatory effects on human neutrophils. Int Arch Allergy Immunol 1996;110:52-56.
37. Mousli M, Bronner C, Bockaert J, Rout B, Landry Y. Interaction of substance P, compound 48/80 and mastopran with the α-subunit C-terminal of G-protein. Immunol Lett 1990;25:355-357.
38. Arnold R, König B, König W. G-proteins in allergy. Clin Exp Allergy 1997;27:1-7.
39. 4 and the role in allergic leukocyte recruitment. Clin Exp Allergy 1997;27:445-451.